According to Zhitong Finance APP, Harbin Medisan Pharmaceutical (002900.SZ) announced that the company and its wholly-owned subsidiary, Lanxi Harbin Medisan Pharmaceutical Co., Ltd. ("Lanxi Pharmaceutical"), recently participated in the bidding work organized by the National Organization of Pharmaceutical Central Procurement and Use Joint Procurement Office ("Joint Procurement Office") for the 10th batch of national centralized procurement of pharmaceuticals. The company's pharmaceuticals, including Esmolol Hydrochloride Injection, Aketone Cocoa Injection, Potassium Chloride Injection, and Lanxi Pharmaceutical's drugs, including Citric Acid Tanshinone Tablets, are intended to be awarded in this centralized procurement.